Similar Search Results

Research scientist productivity and firm size : evidence from panel data on investors

Kim, Jinyoung (contributor); Lee, Sangjoon John (contributor) - 2004

Persistent link: https://www.econbiz.de/10002707795

TRIPS flexibilities on patent enforcement : lessons from some developed countries relating to pharmaceutical patent protection

Sarnoff, Joshua D. - 2020

Persistent link: https://www.econbiz.de/10012433661

How do patent-based measures inform product commercialization? : the case of the United States pharmaceutical industry

Su, Hsin-Ning; Lin, Yi-Siang - In: Journal of engineering and technology management : JET-M 50 (2018), pp. 24-38

Persistent link: https://www.econbiz.de/10011957365

Innovation performance feedback and patent acquisition from the market : a behavioral perspective

Lee, Jongseon; Kim, Nami - In: Managerial and decision economics : MDE ; the … 44 (2023) 6, pp. 3199-3214

Persistent link: https://www.econbiz.de/10014340883

Pharmainnovationen : überragende Position der USA und Schwächen der deutschen Forschung

Eckert, Andreas; Maennig, Wolfgang - In: Wirtschaftsdienst : Zeitschrift für Wirtschaftspolitik 101 (2021) 8, pp. 652-659

zugrundeliegenden Ankerpatenten ist die Dominanz der USA mit 62 % noch größer - aus Deutschland kommen nur 7 % der Ankerpatente. US … such as patent applications. We present a novel indicator of pharmaceutical innovativeness that focuses on global medical …

Persistent link: https://www.econbiz.de/10012663030

The NBER Orange Book Dataset : A User's Guide

Durvasula, Maya; Hemphill, C. Scott; Ouellette, Lisa … - National Bureau of Economic Research - 2022

This paper introduces a newly digitized, open-access version of the Food and Drug Administration's "Orange Book"--a linkage between approved small-molecule drugs and the patents that protect them. The Orange Book also reports any applicable regulatory exclusivity that prevents competitive entry....

Persistent link: https://www.econbiz.de/10013462677